Padraig Andrew O'Connor - 13 Feb 2026 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP, Global Operations
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
13 Feb 2026
Net transactions value
-$73,759
Form type
4
Filing time
18 Feb 2026, 17:58:55 UTC
Previous filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Connor Padraig Andrew EVP, Global Operations 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH /s/ Susan Thompson, Attorney-in-Fact 18 Feb 2026 0002098740

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +500 +11% $0.000000 4,986 13 Feb 2026 Direct F1
transaction BSX Common Stock Tax liability $14,871 -199 -4% $74.73 4,787 13 Feb 2026 Direct
transaction BSX Common Stock Options Exercise $0 +1,190 +25% $0.000000 5,977 14 Feb 2026 Direct F1
transaction BSX Common Stock Tax liability $33,554 -449 -7.5% $74.73 5,528 14 Feb 2026 Direct
transaction BSX Common Stock Options Exercise $0 +905 +16% $0.000000 6,433 16 Feb 2026 Direct F1
transaction BSX Common Stock Tax liability $25,333 -339 -5.3% $74.73 6,094 16 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -500 -25% $0.000000 1,502 13 Feb 2026 Common Stock 500 Direct F1, F2
transaction BSX Restricted Stock Units Options Exercise $0 -1,190 -50% $0.000000 1,190 14 Feb 2026 Common Stock 1,190 Direct F1, F3
transaction BSX Restricted Stock Units Options Exercise $0 -905 -100% $0.000000 0 16 Feb 2026 Common Stock 905 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.